School of Public Health, Wannan Medical College, 22 West Wenchang Road, 241002, Wuhu, Anhui Province, China.
School of Clinical Medicine, Wannan Medical College, 22 West Wenchang Road, 241002, Wuhu, Anhui Province, China.
BMC Endocr Disord. 2024 Jan 2;24(1):2. doi: 10.1186/s12902-023-01528-7.
While dyslipidemia has been recognized as a potential risk factor for hyperuricemia, there is currently a dearth of large-scale data specifically focused on studying the relationship between these two conditions. To address this gap, the present study analyzed a dataset of 298,891 physical examination records to investigate in greater detail the clinical classification and compositional relationship between hyperuricemia and dyslipidemia.
For this investigation, a cross-sectional research design was utilized to analyze physical examination data that was gathered from Yijishan Hospital in Wuhu, China between 2011 and 2016. Logistic regression was employed to examine the association between hyperuricemia and dyslipidemia. Furthermore, the association between hyperuricemia and dyslipidemia was evaluated based on the clinical classifications of dyslipidemia and its components.
A total of 298,891 participants from China (124,886 [41.8%] females) were included in the study, with an age range of 18 to 90 years (mean [SD]: 47.76 [13.54] years). In multivariate analysis, the odds of hyperuricemia was 1.878 times higher in patients with dyslipidemia compared to those without dyslipidemia (95% confidence interval [CI]: 1.835-1.922). In the clinical classification of dyslipidemia, individuals with hypertriglyceridemia and mixed hyperlipidemia had 1.753 times (95% CI: 1.706-1.802) and 1.925 times (95% CI: 1.870-1.982) higher odds of hyperuricemia, respectively, compared to those without dyslipidemia. Among the components of dyslipidemia, the odds ratios for hyperuricemia in individuals in the fourth quartile compared to those in the first quartile were 3.744 (95% CI: 3.636-3.918) for triglycerides, 1.518 (95% CI: 1.471-1.565) for total cholesterol, and 1.775 (95% CI: 1.718 - 1.833) for non-high-density lipoprotein cholesterol.
Dyslipidemia has been independently linked with hyperuricemia. Moreover, the elevation of triglycerides or total cholesterol levels, including conditions such as hypertriglyceridemia and mixed hyperlipidemia, have been observed to have a positive association with the development of hyperuricemia.
虽然血脂异常已被认为是高尿酸血症的一个潜在危险因素,但目前缺乏专门针对这两种情况之间关系的大规模数据。为了解决这一差距,本研究分析了 298891 份体检记录数据集,以更详细地研究高尿酸血症和血脂异常的临床分类和组成关系。
本研究采用横断面研究设计,对 2011 年至 2016 年在中国芜湖弋矶山医院采集的体检数据进行分析。采用 logistic 回归分析高尿酸血症与血脂异常之间的关系。此外,根据血脂异常的临床分类及其成分评估高尿酸血症与血脂异常之间的关系。
本研究共纳入 298891 名来自中国的参与者(女性 124886 名[41.8%]),年龄为 18 至 90 岁(平均[SD]:47.76[13.54]岁)。多变量分析显示,与无血脂异常者相比,血脂异常者发生高尿酸血症的几率高 1.878 倍(95%置信区间[CI]:1.835-1.922)。在血脂异常的临床分类中,与无血脂异常者相比,高甘油三酯血症和混合性高脂血症患者发生高尿酸血症的几率分别高 1.753 倍(95%CI:1.706-1.802)和 1.925 倍(95%CI:1.870-1.982)。在血脂异常的成分中,与第 1 四分位相比,第 4 四分位的个体发生高尿酸血症的比值比(OR)分别为 3.744(95%CI:3.636-3.918)、1.518(95%CI:1.471-1.565)和 1.775(95%CI:1.718-1.833)。
血脂异常与高尿酸血症独立相关。此外,甘油三酯或总胆固醇水平升高,包括高甘油三酯血症和混合性高脂血症等情况,与高尿酸血症的发生呈正相关。